Colchicine for #gout patients with CV risk: - since it has a purely anti-inflammatory effect, risk of acute CV events in pts w/ high CV risk is reduced. vs. NSAIDs/steroids, colchicine remains to be a safer option for gout prophylaxis @rheumnow #APLAR25 https://t.co/WgfTcIleMd